RE: New NCP Forcasts With just the market penetration suggested in the report, we are light by 0.80c. And that's at a hyper conservative 1% market share in the US market only.
A more realistic figure is 10% or more and now we're in the ballpark beech has suggested for some time. This canine cancer line is the best thing that can happen to this company...bar none.....
Wait for the distribution partnership in the next month or so and then watch us challenge all time highs.....there is no way that the market is anywhere near baking in the full potential of just the first doggy cancer treatment....let alone the next one.